EP3510034
SETIN IMÍDASÓ-KÍNÓLÍN SEM NLRP3 STILLAR
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.2.2018EP published:
22.4.2020EP application number:
18707612.0
EP translation filed:
30.6.2020Grant published:
15.8.2020EPO information:
European Patent Register
Max expiry date:
15.2.2038Expiry date:
15.2.2026Next due date:
28.2.2026
Title:
SUBSTITUTED IMIDAZO-QUINOLINES AS NLRP3 MODULATORS
Timeline
Today
16.2.2018EP application
22.4.2020EP Publication
30.6.2020Translation submitted
15.8.2020Registration published
15.2.2026Expires
Owner
Name:
Innate Tumor Immunity, Inc.Address:
Route 206 and Province Line Road, Princeton, New Jersey 08543, US
Inventor
Name:
GLICK, GaryAddress:
Ann Arbor, MI 48103, US
Name:
GHOSH, ShomirAddress:
Brookine, MA 02446, US
Name:
ROUSH, William R.Address:
Tequesta, FL 33469, US
Name:
OLHAVA, Edward JamesAddress:
Newton, MA 02460, US
Name:
O'MALLEY, DanielAddress:
Princeton, New Jersey 08543, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201762460677 PDate:
17.2.2017Country:
US
Number:
201762490881 PDate:
27.4.2017Country:
US
Number:
201762573991 PDate:
18.10.2017Country:
US
Classification
Categories:
C07D 471/04, A61P 35/00, A61P 37/00, A61K 31/437
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 12.1.2021
Expires: 15.2.2022
Payer: Árnason Faktor ehf.
Number: 5
Paid: 5.1.2022
Expires: 15.2.2023
Payer: Árnason Faktor ehf.
Number: 6
Paid: 5.1.2023
Expires: 15.2.2024
Payer: Árnason Faktor ehf.
Number: 6
Paid: 5.1.2023
Expires: 15.2.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 9.1.2024
Expires: 15.2.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 16.1.2025
Expires: 15.2.2026
Payer: Árnason Faktor ehf.